wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Pharm - Cardio Block 1 (Lecture 1/2/3)

Total questions: 82

Worksheet time: 48mins

Name
Class
Date
1.

The resistance or friction that the arterioles have against the flow of blood

a)

Peripheral resistance

b)

Cardiac output

c)

Heart rate

d)

Stroke volume

2.

The amount of blood that is pumped out of the heart per minute

a)

Peripheral resistance

b)

Cardiac output

c)

Heart rate

d)

Stroke volume

3.

number of beats/minute

a)

Peripheral resistance

b)

Cardiac output

c)

Heart rate

d)

Stroke volume

4.

the amount of blood pumped per beat

a)

Peripheral resistance

b)

Cardiac output

c)

Heart rate

d)

Stroke volume

5.

Stimulation of the SNS will cause all (HR, SV, PR) to rise ***

a)

Stress

b)

Exercise

c)

Pheochromocytoma

d)

Age

6.

are activated to cause vasoconstriction

a)

Alpha-1 receptors

b)

Beta-1 receptors

c)

Angiotensin II

d)

Aldosterone

7.

are activated to cause increased HR & force of myocardial contraction

a)

Alpha-1 receptors

b)

Beta-1 receptors

c)

Angiotensin II

d)

Aldosterone

8.

causes vasoconstriction and the release of aldosterone

a)

Alpha-1 receptors

b)

Beta-1 receptors

c)

Angiotensin II

d)

Aldosterone

9.

causes retention of sodium and water

a)

Alpha-1 receptors

b)

Beta-1 receptors

c)

Angiotensin II

d)

Aldosterone

10.

BP =

a)

CO x PR

b)

HR x SV

c)

EDV - ESV

11.

HR x SV

a)

CO x PR

b)

HR x SV

c)

EDV - ESV

12.

SV =

a)

CO x PR

b)

HR x SV

c)

EDV - ESV

13.

volume of blood in ventricles at end of diastole (end diastolic pressure) *stretch*

a)

Preload

b)

Afterload

14.

Resistance left ventricle must overcome to circulate blood *squeeze*

a)

Preload

b)

Afterload

15.

Preload increased in

a)

Hypervolemia

b)

Regurgitation of cardiac valves

c)

Heart failure

d)

Hypertension

e)

Vasoconstriction

16.

Afterload increased in

a)

Hypervolemia

b)

Regurgitation of cardiac valves

c)

Heart failure

d)

Hypertension

e)

Vasoconstriction

17.

↑ Preload

a)

↑ SV

b)

↑ EDV

c)

↓ SV

d)

↑ ESV

e)

↓ ESV

18.

↑ Afterload

a)

↑ SV

b)

↑ EDV

c)

↓ SV

d)

↑ ESV

e)

↓ ESV

19.

↑ Inotropy

a)

↑ SV

b)

↑ EDV

c)

↓ SV

d)

↑ ESV

e)

↓ ESV

20.

Drugs that Interfere with the Renin-Angiotensin-aldosterone System (RAAs) ***

a)

Angiotensin Converting Enzyme (ACE) Inhibitors

b)

Angiotensin Receptor Blockers (ARBs)

c)

Renin Inhibitors (tekturna)

d)

Alpha Blockers

e)

Beta Blockers

21.

MOA: inhibits conversion of angiotensin I into angiotensin II

a)

Angiotensin Converting Enzyme (ACE) Inhibitors

b)

Angiotensin Receptor Blockers (ARBs)

c)

Renin Inhibitors (tekturna)

d)

Alpha Blockers

e)

Beta Blockers

22.

The “-prils”

a)

Angiotensin Converting Enzyme (ACE) Inhibitors

b)

Angiotensin Receptor Blockers (ARBs)

c)

Renin Inhibitors (tekturna)

d)

Alpha Blockers

e)

Beta Blockers

23.

MOA: blocks angiotensin II receptors on target tissue

a)

Angiotensin Converting Enzyme (ACE) Inhibitors

b)

Angiotensin Receptor Blockers (ARBs)

c)

Renin Inhibitors (tekturna)

d)

Alpha Blockers

e)

Beta Blockers

24.

The “–artans”

a)

Angiotensin Converting Enzyme (ACE) Inhibitors

b)

Angiotensin Receptor Blockers (ARBs)

c)

Renin Inhibitors (tekturna)

d)

Alpha Blockers

e)

Beta Blockers

25.

Drugs that affect the Sympathetic Nervous System

a)

Centrally acting sympatholytics

b)

Neuronal blockers

c)

Alpha blockers

d)

Beta blockers

e)

Diuretics

26.

acts on the vasomotor center of the medulla oblongata and stimulates inhibitory receptors reducing the activity of sympathetic nerves that control heart rate and CO

a)

Centrally acting sympatholytics

b)

Neuronal blockers

c)

Alpha blockers

d)

Beta blockers

e)

Diuretics

27.

Clonidine (catapres)

a)

Centrally acting sympatholytics

b)

Neuronal blockers

c)

Alpha blockers

d)

Beta blockers

e)

Diuretics

28.

Guanethidine causes significant inhibition of sympathetic activity; reserved for hypertension that does not respond to other drugs

a)

Centrally acting sympatholytics

b)

Neuronal blockers

c)

Alpha blockers

d)

Beta blockers

e)

Diuretics

29.

smooth muscle contraction, peripheral vascular resistance

a)

Alpha 1

b)

Beta 1

c)

Alpha 2

d)

Beta 2

30.

cardiac stimulation

a)

Alpha 1

b)

Beta 1

c)

Alpha 2

d)

Beta 2

31.

responsible for negative feedback to release norepinephrine

a)

Alpha 1

b)

Beta 1

c)

Alpha 2

d)

Beta 2

32.

Predominant receptor in the heart

a)

Alpha 1

b)

Beta 1

c)

Alpha 2

d)

Beta 2

33.

Predominant receptor in the smooth muscle of some organs and tissues (skeletal blood vessels and coronary arteries as well as lung)

a)

Alpha 1

b)

Beta 1

c)

Alpha 2

d)

Beta 2

34.

MOA: b blockers inhibit sustained sympathetic nervous system activation

a)

Beta blockers

b)

Alpha-1 blockers

c)

Vasodilators

d)

Dihydropyridines (CCB)

e)

Non-dihydropyridines (CCB)

35.

Identified by "-olol"

a)

Beta blockers

b)

Alpha-1 blockers

c)

Vasodilators

d)

Dihydropyridines (CCB)

e)

Non-dihydropyridines (CCB)

36.

will affect heart (decrease sympathetic stimulation & slow down contractions) and lungs (decrease sympathetic bronchodilation leads to bronchoconstriction)

a)

Non-selective beta blockers

b)

Selective beta blockers

37.

-MOA: block alpha-1 receptor binding of epinephrine & norepinephrine

-Results in vasodilation

-Reduces peripheral resistance (a factor in cardiac workload)

a)

Beta blockers

b)

Alpha-1 blockers

c)

Vasodilators

d)

Dihydropyridines (CCB)

e)

Non-dihydropyridines (CCB)

38.

The "–zosins"

a)

Beta blockers

b)

Alpha-1 blockers

c)

Vasodilators

d)

Dihydropyridines (CCB)

e)

Non-dihydropyridines (CCB)

39.

Drugs that affect the cardiac and vascular smooth muscle

a)

Beta blockers

b)

Alpha-1 blockers

c)

Vasodilators

d)

Dihydropyridines (CCB)

e)

Non-dihydropyridines (CCB)

40.

-Drugs that decrease sympathetic tone will cause vasodilation by increasing the diameter of the vessel

-Drugs that act directly on the vascular smooth muscle also cause vasodilation

a)

Beta blockers

b)

Alpha-1 blockers

c)

Vasodilators

d)

Dihydropyridines (CCB)

e)

Non-dihydropyridines (CCB)

41.

Arterial dilation; for hypertension; decr afterload ***

a)

Hydralazine (Apresoline)

b)

Minoxidil (Loniten)

c)

Nitroglycerin

d)

Nitroprusside

42.

Venous & arterial (lesser) dilation; for heart failure ***

a)

Hydralazine (Apresoline)

b)

Minoxidil (Loniten)

c)

Nitroglycerin

d)

Nitroprusside

43.

potent vasodilators; nifedipine, amlodipine, nicardipine, etc.

a)

Beta blockers

b)

Alpha-1 blockers

c)

Vasodilators

d)

Dihydropyridines (CCB)

e)

Non-dihydropyridines (CCB)

44.

effect cardiac conduction, contractility (negative inotropic medication), decr. HR, less vasodilation; verapamil, diltiazem, etc.

a)

Beta blockers

b)

Alpha-1 blockers

c)

Vasodilators

d)

Dihydropyridines (CCB)

e)

Non-dihydropyridines (CCB)

45.

Hypertension, CAD/angina pectoris →

a)

dihydropyridines or non-dihydropyridines

b)

ONLY non-dihydropyridines

46.

Arrhythmias

a)

dihydropyridines or non-dihydropyridines

b)

ONLY non-dihydropyridines

47.

Increase excretion of water and salt from the body

a)

Centrally acting sympatholytics

b)

Neuronal blockers

c)

Alpha blockers

d)

Beta blockers

e)

Diuretics

48.

Medicines that reduce preload

a)

ACEI

b)

BB

c)

Nitrates

d)

Diuretics

e)

CCB

49.

Medicines that reduce afterload

a)

ACEI

b)

BB

c)

CCB

d)

Hydralazine

e)

Nitroprusside

50.

Caution w angioedema

a)

ACEI

b)

ARB

c)

renin inhibitor

d)

K-sparing diuretic

e)

Nonselective beta blocker

51.

Caution w pregnancy

a)

ACEI

b)

ARB

c)

renin inhibitor

d)

K-sparing diuretic

e)

Nonselective beta blocker

52.

Caution w hyperkalemia

a)

ACEI

b)

ARB

c)

renin inhibitor

d)

K-sparing diuretic

e)

Nonselective beta blocker

53.

Avoid in Asthma/COPD

a)

ACEI

b)

ARB

c)

renin inhibitor

d)

K-sparing diuretic

e)

Nonselective beta blocker

54.

Caution bradycardia

a)

Beta blocker

b)

Non-DHP

c)

Alpha 2 agonist

d)

Thiazide

e)

Loop

55.

Avoid in heart failure

a)

Beta blocker

b)

Non-DHP

c)

Alpha 2 agonist

d)

Thiazide

e)

Loop

56.

Avoid in gout

a)

Beta blocker

b)

Non-DHP

c)

Alpha 2 agonist

d)

Thiazide

e)

Loop

57.

Caution hypokalemia or hyponatremia

a)

Beta blocker

b)

Non-DHP

c)

Alpha 2 agonist

d)

Thiazide

e)

Loop

58.

Antihypertensive medications for Heart Failure

a)

BB +/- ACEI/ARB

b)

ACEI (preferred)/ARB

c)

CCB or Thiazide

59.

Antihypertensive medications for Stable Ischemic Heart Disease (SIHD)

a)

BB +/- ACEI/ARB

b)

ACEI (preferred)/ARB

c)

CCB or Thiazide

60.

Antihypertensive medications for Chronic Kidney Disease

a)

BB +/- ACEI/ARB

b)

ACEI (preferred)/ARB

c)

CCB or Thiazide

61.

Antihypertensive medications for African Americans (unless CKD or other compelling indications)

a)

BB +/- ACEI/ARB

b)

ACEI (preferred)/ARB

c)

CCB or Thiazide

62.

Antihypertensive medications for pregnancy

a)

Nifedipine ER

b)

Labetalol

c)

Methyldopa

d)

Bisoprolol

e)

Carvedilol

63.

Preferred BBs for Heart Failure ***

a)

Bisoprolol

b)

Carvedilol

c)

Metoprolol succinate

d)

Metoprolol tartrate

e)

Atenolol

64.

Which BB should be avoided in SIHD

a)

Bisoprolol

b)

Carvedilol

c)

Metoprolol succinate

d)

Metoprolol tartrate

e)

Atenolol

65.

predominately vasodilate

a)

DHPs

b)

Non DHPs

66.

decrease cardiac contractility/conduction

a)

DHPs

b)

Non DHPs

67.

ACEI

a)

Enalapril

b)

Candesartan

c)

Amlodipine

d)

Furosemide

e)

Aliskiren

68.

ARB

a)

Enalapril

b)

Candesartan

c)

Amlodipine

d)

Furosemide

e)

Aliskiren

69.

DHPs (CCB)

a)

Enalapril

b)

Candesartan

c)

Amlodipine

d)

Furosemide

e)

Aliskiren

70.

Loop

a)

Enalapril

b)

Candesartan

c)

Amlodipine

d)

Furosemide

e)

Aliskiren

71.

Renin inhibitor

a)

Enalapril

b)

Candesartan

c)

Amlodipine

d)

Furosemide

e)

Aliskiren

72.

Alpha-1 Blocker

a)

Clonidine

b)

Methyldopa

c)

Doxazosin

d)

Hydralazine

e)

Minoxidil

73.

Alpha-2 Agonist

a)

Clonidine

b)

Methyldopa

c)

Doxazosin

d)

Hydralazine

e)

Minoxidil

74.

Direct vasodilators

a)

Clonidine

b)

Methyldopa

c)

Doxazosin

d)

Hydralazine

e)

Minoxidil

75.

Non-DHPs

a)

Diltiazem

b)

Verapamil

c)

Hydrocholorothiazide

d)

Chlorthalidone

76.

Thiazides

a)

Diltiazem

b)

Verapamil

c)

Hydrocholorothiazide

d)

Chlorthalidone

77.

K-Sparing/Aldosterone Antagonist

a)

Triamterene/HCTZ

b)

Eplernone

c)

Spironlactone

78.

K-sparing

a)

Triamterene/HCTZ

b)

Eplernone

c)

Spironlactone

79.

Selective beta blocker

a)

Atenolol

b)

Betaxolol

c)

Bisoprolol

d)

Nadolol

e)

Nebivolol

80.

Selective beta blocker

a)

Metoprolol succinate

b)

Metoprolol tartate

c)

Acebutolol

d)

Carvedilol

e)

Nadolol

81.

Nonselective beta blockers

a)

Nadolol

b)

Propanolol

c)

Timolol

d)

Nebivolol

e)

Atenolol

82.

Nonselective Beta/Alpha-1 Blockers

a)

Carvedilol

b)

Labetolol

c)

Nebivolol

d)

Bisoprolol

e)

Atenolol